Lexicon Pharmaceuticals | LXRX - Ebitda





Ebitda Cambiamento Data
Abbott USD 3.09B 44M 2025-09
Acadia Pharmaceuticals USD 35.76M 447K 2025-09
Agios Pharmaceuticals USD -115.49M 10.3M 2025-09
Akebia Therapeutics USD 14.03M 17.19M 2025-03
Alnylam Pharmaceuticals USD 145.22M 236.56M 2025-12
AstraZeneca USD 5.23B 272M 2025-09
BioMarin Pharmaceutical USD -24.17M 18.91M 2025-12
Coherus Biosciences USD -43.33M 4.7M 2025-09
Eli Lilly USD 7.88B 378.1M 2025-09
Esperion Therapeutics USD -9.93M 24.99M 2025-09
Halozyme Therapeutics USD 21.9M 226.34M 2025-12
Illumina USD 332M 12M 2025-09
Insmed USD -314.19M 31.48M 2025-12
Ironwood Pharmaceuticals USD 81.81M 31.71M 2025-09
J&J USD 9.52B 389M 2025-09
Lexicon Pharmaceuticals USD -12.04M 15.95M 2025-09
MacroGenics USD 21.95M 55.39M 2025-09
MannKind USD 17.92M 8.17M 2025-09
Merck USD 8.39B 1.97B 2025-09
Moderna USD -790M 582M 2025-12
Novartis USD 4.77B 1.11B 2025-12
PTC Therapeutics USD 20.63M 53.74M 2025-09
Puma Biotechnology USD 729K 11.36M 2024-06
Sarepta Therapeutics USD -168.03M 294.45M 2025-09
Thermo Fisher Scientific USD 3.17B 335M 2025-12
Ultragenyx Pharmaceutical USD -156.79M 65.44M 2025-09
United Therapeutics USD 379.5M 83.4M 2025-12
Vanda Pharmaceuticals USD -8.31M 2.37M 2024-12